Last reviewed 2026-04-20 · How we verify

PF-07871987 Influenza saRNA (pf-07871987-influenza-sarna)

Pfizer · FDA-approved active Quality 35/100

PF-07871987 Influenza saRNA (generic name: pf-07871987-influenza-sarna) is a RNA-based therapeutic drug developed by Pfizer. It is currently FDA-approved for Influenza.

PF-07871987 Influenza saRNA is a marketed drug by Pfizer Inc. for Influenza treatment. It has generated $21.2B in revenue. The mechanism of action is not specified. This drug has 1 trial and 0 publications. It is a first-in-class treatment for Influenza.

At a glance

Generic name	pf-07871987-influenza-sarna
Sponsor	Pfizer
Drug class	RNA-based therapeutic
Target	influenza virus
Therapeutic area	Infectious Disease
Phase	FDA-approved

Approved indications

Influenza

Common side effects

No common side effects on file.

Drug interactions

Atazanavir
Ritonavir
CYP3A4 inhibitors
CYP3A4 inducers

Key clinical trials

A Study To Learn About The Study Vaccine (Called Self-Amplifying Ribonucleic Acid (RNA)) For The Prevention of Influenza (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

PF-07871987 Influenza saRNA CI brief — competitive landscape report
PF-07871987 Influenza saRNA updates RSS · CI watch RSS
Pfizer portfolio CI

Frequently asked questions about PF-07871987 Influenza saRNA

What is PF-07871987 Influenza saRNA?

PF-07871987 Influenza saRNA (pf-07871987-influenza-sarna) is a RNA-based therapeutic drug developed by Pfizer, indicated for Influenza.

What is PF-07871987 Influenza saRNA used for?

PF-07871987 Influenza saRNA is indicated for Influenza.

Who makes PF-07871987 Influenza saRNA?

PF-07871987 Influenza saRNA is developed and marketed by Pfizer (see full Pfizer pipeline at /company/pfizer).

What is the generic name of PF-07871987 Influenza saRNA?

pf-07871987-influenza-sarna is the generic (nonproprietary) name of PF-07871987 Influenza saRNA.

What drug class is PF-07871987 Influenza saRNA in?

PF-07871987 Influenza saRNA belongs to the RNA-based therapeutic class. See all RNA-based therapeutic drugs at /class/rna-based-therapeutic.

What development phase is PF-07871987 Influenza saRNA in?

PF-07871987 Influenza saRNA is FDA-approved (marketed).

What does PF-07871987 Influenza saRNA target?

PF-07871987 Influenza saRNA targets influenza virus and is a RNA-based therapeutic.

Drug class: All RNA-based therapeutic drugs
Target: All drugs targeting influenza virus
Manufacturer: Pfizer — full pipeline
Therapeutic area: All drugs in Infectious Disease
Indication: Drugs for Influenza
Compare: PF-07871987 Influenza saRNA vs similar drugs
Pricing: PF-07871987 Influenza saRNA cost, discount & access